A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.

Clinical trial NCT07593027 · RECRUITING

Trial details

NCT number: NCT07593027
Sponsor: ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension PAH

Start date: 2026-04-30
Primary completion: 2027-10-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.